Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Shun Yen

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Cardiovascular Diabetology|May 10, 2023
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort studyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Diabetes & Metabolism|March 27, 2023
Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in TaiwanFu-Shun Yen, Jing-Yang Huang, Shih-Yi Lin, et al.
Journal of Diabetes Investigation|June 23, 2020
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort studyFu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort StudyFu-Shun Yen, Shu-Hao Chang, James Cheng-Chung Wei, et al.
Annals of Internal Medicine|April 29, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney DiseaseFu-Shun Yen, Chii-Min Hwu, Jia-Sin Liu, et al.
Diabetes Research and Clinical Practice|July 2, 2025
Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetesFu-Shun Yen, Jing-Yang Huang, Chen Dong, et al.
Diabetes Care|November 15, 2022
The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver InjuryFu-Shun Yen, Ming-Chih Hou, Chun-Wei Pan, et al.
Journal of Diabetes Investigation|September 16, 2021
Epidemiological characteristics of diabetic kidney disease in TaiwanJun-Sing Wang, Fu-Shun Yen, Kun-Der Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2020
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosisFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
International Journal of Medical Sciences|June 9, 2021
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with GoutFu-Shun Yen, James Cheng-Chung Wei, Chia-Ling Chang, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Cardiovascular Diabetology|May 10, 2023
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort studyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Diabetes & Metabolism|March 27, 2023
Maternal autoimmune disease associated with a higher risk of offspring with type 1 diabetes: A nationwide mother-child cohort study in TaiwanFu-Shun Yen, Jing-Yang Huang, Shih-Yi Lin, et al.
Journal of Diabetes Investigation|June 23, 2020
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort studyFu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort StudyFu-Shun Yen, Shu-Hao Chang, James Cheng-Chung Wei, et al.
Annals of Internal Medicine|April 29, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney DiseaseFu-Shun Yen, Chii-Min Hwu, Jia-Sin Liu, et al.
Diabetes Research and Clinical Practice|July 2, 2025
Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetesFu-Shun Yen, Jing-Yang Huang, Chen Dong, et al.
Diabetes Care|November 15, 2022
The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver InjuryFu-Shun Yen, Ming-Chih Hou, Chun-Wei Pan, et al.
Journal of Diabetes Investigation|September 16, 2021
Epidemiological characteristics of diabetic kidney disease in TaiwanJun-Sing Wang, Fu-Shun Yen, Kun-Der Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2020
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosisFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
International Journal of Medical Sciences|June 9, 2021
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with GoutFu-Shun Yen, James Cheng-Chung Wei, Chia-Ling Chang, et al.
Pageof 11